dc.contributor.author
Casadó Llombart, Sergi
dc.contributor.author
Gheytasi, Hoda
dc.contributor.author
Ariño, Silvia
dc.contributor.author
Consuegra-Fernández, Marta
dc.contributor.author
Armiger Borràs, Noelia
dc.contributor.author
Kostov, Belchin
dc.contributor.author
Ramos Casals, Manuel
dc.contributor.author
Brito Zerón, María del Pilar
dc.contributor.author
Lozano Soto, Francisco
dc.date.issued
2023-06-26T16:02:54Z
dc.date.issued
2023-06-26T16:02:54Z
dc.date.issued
2022-03-18
dc.date.issued
2023-06-26T16:02:54Z
dc.identifier
https://hdl.handle.net/2445/199879
dc.description.abstract
Primary Sjögren's syndrome (pSS) is an autoimmune disease triggered by a combination of environmental and host genetic factors, which results in the focal lymphocytic infiltration of exocrine glands causing eye and mouth dryness. Glandular infiltrates include T and B cell subsets positive for CD5 and/or CD6, two surface scavenger receptors involved in the fine-tuning of intracellular signals mediated by the antigen-specific receptor complex of T (TCR) and B (BCR) cells. Moreover, the epithelial cells of inflamed glands overexpress CD166/ALCAM, a CD6 ligand involved in homo and heterotypic cell adhesion interactions. All this, together with the reported association of functionally relevant single nucleotide polymorphisms (SNPs) of CD5, CD6, and CD166/ALCAM with the risk or prognosis of some immune-mediated inflammatory disorders, led us to investigate similar associations in a local cohort of patients with pSS. The logistic regression analyses of individual SNPs showed the association of CD5 rs2241002T with anti-Ro/La positivity, CD6 rs17824933C with neutropenia, and CD6 rs11230563T with increased leukopenia and neutropenia but decreased peripheral nervous system EULAR Sjögren's syndrome disease activity index (ESSDAI). Further analyses showed the association of haplotypes from CD5 (rs2241002T-rs2229177C) with anemia and thrombocytopenia, CD6 (rs17824933G-rs11230563C-rs12360861G) with cutaneous ESSDAI, and CD166/ALCAM (rs6437585C-rs579565A-rs1044243C and rs6437585C-rs579565G-rs1044243T) with disease susceptibility and several analytical parameters (anti-nuclear antibodies, neurological ESSDAI, and hematologic cytopenias). These results support the relevance of gene variation at loci coding for cell surface receptors involved in the modulation of T and B lymphocyte activation (CD5, CD6) and epithelial-immune cell adhesion (CD166/ALCAM) in modulating the clinical and analytical outcomes in patients with pSS
dc.format
application/pdf
dc.publisher
Frontiers Media
dc.relation
Reproducció del document publicat a: https://doi.org/10.3389/fmed.2022.822290
dc.relation
Frontiers in Medicine, 2022, vol. 9, p. 822290
dc.relation
https://doi.org/10.3389/fmed.2022.822290
dc.rights
cc-by (c) Casadó Llombart, Sergi et al., 2022
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biomedicina)
dc.subject
Malalties immunitàries
dc.subject
Polimorfisme genètic
dc.subject
Immunologic diseases
dc.subject
Genetic polymorphisms
dc.title
Gene variation at immunomodulatory and cell adhesion molecules loci impacts primary Sjögren's syndrome
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion